$7.040
-0.527 (-7.49%)終値時点
- High
- 7.240
- Open
- 6.840
- VWAP
- 6.86
- Vol
- 11.63M
- Mkt Cap
- 1.43M
- Low
- 6.290
- Amount
- 79.77M
- EV/EBITDA, TTM
- 0.00
180 Life Sciences Corp. is a biotechnology company, which focuses on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Its programs include Anti-TNF (Clinical), Synthetic Cannabinoid Analogs (SCAs), and a7nAChR (Preclinical). The Company also operates a back-end technology platform to operate an online blockchain casino.
バリュエーション指標
イベントタイムライン
ニュース
4.509-02BenzingaEXCLUSIVE: Top 20 Most-Searched Stocks on Benzinga Pro for August – How Do Opendoor, Palantir, BitMine Immersion, and Apple Rank?
9.508-15BenzingaWhy KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
4.508-15BenzingaStock Market Today: S&P 500, Nasdaq 100 Futures Trade Mixed— UnitedHealth, 180 Life Sciences, Intel In Focus
7.008-15BenzingaApplied Materials Issues Weak Outlook, Joins Globant, Sandisk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
2.008-15Benzinga180 Life Sciences Stock Slides After-Hours As Ethereum's Decline Triggers Massive Sell-Off
ATNF FAQ — answered by Alphio AI
180 Life Sciences Corp. is a biotechnology company, which focuses on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Its programs include Anti-TNF (Clinical), Synthetic Cannabinoid Analogs (SCAs), and a7nAChR (Preclinical). The Company also operates a back-end technology platform to operate an online blockchain casino. It operates in the Technology sector (PHARMACEUTICAL PREPARATIONS industry).
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。